|
Philip Jochelson M.D. has served as our Senior Vice President and Chief Medical Officer since April 2005. From November 1998 to March 2005 Dr. Jochelson was employed by Neurocrine Biosciences Inc. a biopharmaceutical company where he had responsibility for the clinical development of the company�s programs for the treatment of insomnia. During his more than six year tenure with Neurocrine Dr. Jochelson successfully progressed the insomnia programs from Phase I through to NDA submission. Previously Dr. Jochelson held positions of increasing responsibility in clinical development at Boehringer Ingelheim Canada a pharmaceutical company and Alliance Pharmaceutical Corp. Dr. Jochelson is a licensed physician in California Canada and South Africa. He graduated from the University of Witwatersrand Medical School in South Africa and subsequently received postgraduate residency training in internal medicine and anesthesiology in Canada. | 